BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 26154784)

  • 1. Synthetic Cannabinoid-Related Illnesses and Deaths.
    Trecki J; Gerona RR; Schwartz MD
    N Engl J Med; 2015 Jul; 373(2):103-7. PubMed ID: 26154784
    [No Abstract]   [Full Text] [Related]  

  • 2. The "new" marijuana.
    Wells DL; Ott CA
    Ann Pharmacother; 2011 Mar; 45(3):414-7. PubMed ID: 21325097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A multicenter survey of poisoning after consumption of products containing synthetic chemicals in Japan].
    Kamijo Y
    Chudoku Kenkyu; 2014 Sep; 27(3):227-9. PubMed ID: 27526519
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug poisoning deaths in the United States, 1980-2008.
    Warner M; Chen LH; Makuc DM; Anderson RN; Miniño AM
    NCHS Data Brief; 2011 Dec; (81):1-8. PubMed ID: 22617462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic cannabinoid poisoning: A growing health concern.
    Phillips J; Lim F; Hsu R
    Nursing; 2016 Nov; 46(11):34-41. PubMed ID: 27673323
    [No Abstract]   [Full Text] [Related]  

  • 6. Psychiatric sequelae of Spice, K2, and synthetic cannabinoid receptor agonists.
    Benford DM; Caplan JP
    Psychosomatics; 2011; 52(3):295. PubMed ID: 21565605
    [No Abstract]   [Full Text] [Related]  

  • 7. Geographic distribution of synthetic cannabinoid exposures reported to Texas poison centers.
    Forrester MB; Haywood T
    Am J Drug Alcohol Abuse; 2012 Nov; 38(6):603-8. PubMed ID: 22571605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic Cannabinoid Abuse in Adolescents: A Case Series.
    Besli GE; Ikiz MA; Yildirim S; Saltik S
    J Emerg Med; 2015 Nov; 49(5):644-50. PubMed ID: 26293411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bradycardia and hypotension after synthetic cannabinoid use: a case series.
    Kane EM; Hinson JS; Jordan CD; Paziana K; Sauber NJ; Rothman RE; Stolbach AI
    Am J Emerg Med; 2016 Oct; 34(10):2055.e1-2055.e2. PubMed ID: 27037136
    [No Abstract]   [Full Text] [Related]  

  • 10. Commentary on Hermanns-Clausen et al. (2013): Spicing things up--the emerging phenomenon of synthetic cannabinoid use.
    Addy PH; Cyril D'Souza D
    Addiction; 2013 Mar; 108(3):545-6. PubMed ID: 23418659
    [No Abstract]   [Full Text] [Related]  

  • 11. Alarm over synthetic cannabinoids.
    Underwood E
    Science; 2015 Jan; 347(6221):473. PubMed ID: 25635070
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute intoxication by synthetic cannabinoids--four case reports.
    Hermanns-Clausen M; Kneisel S; Hutter M; Szabo B; Auwärter V
    Drug Test Anal; 2013; 5(9-10):790-4. PubMed ID: 23696237
    [No Abstract]   [Full Text] [Related]  

  • 13. A characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010.
    Hoyte CO; Jacob J; Monte AA; Al-Jumaan M; Bronstein AC; Heard KJ
    Ann Emerg Med; 2012 Oct; 60(4):435-8. PubMed ID: 22575211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperthermia and severe rhabdomyolysis from synthetic cannabinoids.
    Sweeney B; Talebi S; Toro D; Gonzalez K; Menoscal JP; Shaw R; Hassen GW
    Am J Emerg Med; 2016 Jan; 34(1):121.e1-2. PubMed ID: 26143311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic drugs: bath salts and spice.
    Randolph SA
    Workplace Health Saf; 2014 Feb; 62(2):88. PubMed ID: 24512723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poisoning with illicit substances: toxicology for the anaesthetist.
    Wong GT; Irwin MG
    Anaesthesia; 2013 Jan; 68 Suppl 1():117-24. PubMed ID: 23210561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Emergency of synthetic drugs in the general landscape of addiction].
    Karila L
    Rev Prat; 2012 May; 62(5):661-3. PubMed ID: 22730797
    [No Abstract]   [Full Text] [Related]  

  • 18. Emerging drugs of abuse.
    Haroz R; Greenberg MI
    Med Clin North Am; 2005 Nov; 89(6):1259-76. PubMed ID: 16227062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings.
    Hermanns-Clausen M; Kneisel S; Szabo B; Auwärter V
    Addiction; 2013 Mar; 108(3):534-44. PubMed ID: 22971158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic cannabinoid use in New Zealand: a recent rebound.
    Schep LJ; Slaughter RJ; Temple WA; Lambie BS; Gee P; Watts M; Gresham C
    N Z Med J; 2012 Oct; 125(1364):114-6. PubMed ID: 23242407
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.